| PMAO-(β-NaY0.78Yb0.2Er0.02F4)-Bs:Bn-scFc4D5
|
Fluorescence/optical imaging |
Detecting early stage
breast cancer |
(164) |
| Cy5.5-substrate/AuNP |
Fluorescence/optical imaging |
Detecting protease activity |
(165) |
| Cy5.5-DEVD-DOPAK/AuNP |
Fluorescence/optical
imaging |
Testing caspase-3 to identify apoptosis activity
in cells |
(166) |
| PLNP(Zn1.1Ga1.8Ge0.1O4:Cr3+)-CuS-RGD |
Fluorescence/optical imaging |
Detecting tumor and guiding
therapy |
(167) |
| DNAzymes(Zn-Enz)/AuNP-FAM/BHQ-1, DNAzymes(Cu-Enz)/AuNP-Cy5/BHQ-2 |
Fluorescence/optical imaging |
Tracking ion of
Zn and Cu in alive cell |
(168) |
| CNP(Mtx-Asp-FITC) |
Fluorescence/optical imaging |
Monitoring therapeutic
drug delivery |
(169) |
| Cy7.5-INCeRT |
Fluorescence/optical
imaging |
Monitoring drug diffusion |
(170) |
| QD710-Cy7-PEGylated lipids |
Fluorescence/optical imaging |
Monitoring NP accumulation and dissociation kinetics in tumor |
(171) |
| QD710-Dendron/RGD (InP/ZnS core/shell QDs) |
Fluorescence/optical imaging |
Targeted imaging
tumor cells |
(172) |
| Quantum Dots |
Fluorescence/optical
imaging |
Preclinical imaging |
(173) |
| Cationic oligofluorene substrated POSS |
Ethidium bromide
test |
Imaging double-stranded DNA |
(174) |
| Perylenediimide-containing polysiloxane core and silica shell |
Perylenediimide toxicity |
Detecting nanotoxicity
in living cells |
(175) |
| AB3-UCNP(NaYF4:Yb/Tm/Er)-RB/KE108 |
Up-Converting NP celular imaging |
Monitoring cellular
uptake of nanoparticles and combined with
therapy |
(176) |
| Au@IR-pHPMA |
IR |
Detecting lymph node |
(177) |
| Gadolinium nanostructure
polymers, liposomes, inorganic nanoparticles |
MRI imaging |
Preclinical |
(178) |
| Superparamagnetic
iron-oxide nanoparticles coated with dextran |
MRI imaging |
Clinical use; FDA Approved (Feridex/Endorem) |
(179) |
| Bismuth sulfide (Bi2S3) nanoparticles |
CT scan |
Preclinical |
(180) |
| Iodinated liposomal carriers, inorganic nanostructures |
CT scan |
Preclinical |
(181) |
| Gold particles |
CT scan |
Preclinical |
(182) |
| Alpha(nu) beta(3)-Gd (paramagnetic particle) |
MRI imaging |
Imaging angiogenesis |
(183) |
| Liposomal gadolinium |
MRI imaging |
Imaging placenta as blood-pool contrast |
(184) |
| Her2/neu-Oleosin-30G (Micelles) |
MRI imaging |
Imaging target cells |
(185) |
| G4.5-Gd2O3-PEG |
MRI imaging |
New T1/T2MRI contrast agent |
(186) |
| SPIO |
MRI imaging |
Tracking GFP gene marker |
(187) |
| rHDL-Gd |
MRI imaging |
Imaging and characterizing atherosclerotic plaques |
(188) |
| RBC encapsulated iron particles |
MRI imaging |
Blood-pool contrast with longer lifetime |
(189) |
| USPIO-PEI |
MRI imaging |
Determining nanoparticle
vehicle unpackaging for gene |
(190) |
| PEGMnCaP NPs |
MRI imaging |
PH-activatable contrast in cancer |
(191) |
| Mn-nanotexaphyrin |
MRI imaging |
Imaging lymph node |
(192) |
| Micelles with PTX
and SPIO |
MRI imaging |
Delivering drug and
MRI imaging |
(193) |
| TF-biotinylated perfluocarbon-(Gd-DTPA-BOA)@(doxorubicin/paclitaxel) |
MRI imaging |
Evaluating and quantifying drug delivery
system for vascular
restenosis |
(194) |
| FibPep-ION-Micelles |
MRI imaging |
Detecting and imaging thrombus |
(195) |
| P-selectin-MNP(iron oxide)-PBP |
MRI imaging |
Imaging poststroke neuroinflammation |
(196) |
| Mn-SPIO micella |
MRI imaging |
High power
liver imaging contrast |
(197) |
| TMADM-03 |
MRI imaging |
Imaging pancreatic islet graft |
(198) |
| DHCA functioned IONP labeled hMSCs |
MRI imaging |
Imaging and tracking stem cells |
(199) |
| TCL-SPION-Apt |
MRI imaging |
Imaging prostate
cancer cells and chemotherapy |
(200) |
|
18F-labeled DBCO-PEGylated MSN |
PET |
Imaging tumor |
(201) |
|
125/124I-labeled anti-ICAM-1/PVPh-NP |
PET |
Detecting
pulmonary inflammation |
(202) |
|
64Cu labeled
IT-101 |
PET |
Monitoring pharmacokinetics
and tumor dynamics |
(203) |
|
64Cu labeled
CANF-comb nanoparticle |
PET |
Imaging natriuretic
peptide clearance receptor in prostate
cancer |
(204) |
|
64Cu-TNP |
PET |
Imaging macrophages in inflammatory atherosclerosis |
(205) |
|
64Cu labeled CLIO-VT680 |
PET |
Detecting rejection and immunomodulation in cardiac
allografts |
(206) |
|
64Cu labeled CANF-comb
nanoparticle |
PET |
Imaging atherosclerosis
in artery |
(207) |
|
125I silver nanoparticle |
SPECT |
Monitoring distribution of nanoparticles |
(208) |
|
125I labeled cRGD-PEG-AuNP |
SPECT |
Detecting cancer cells and imaging tumor sites |
(209) |
|
111In labeled lipid/calcium/phosphate
NPs |
SPECT |
Imaging lymph node metastasis |
(210) |
|
111In-MSN labeled neural stem cells |
SPECT |
Tracking glioblastoma |
(211) |
| PSMA-specific aptamer conjugated AuNP |
CT |
Imaging prostate cancer cells |
(212) |
| Liposomal iodine |
CT |
Imaging macrophage-rich
atherosclerotic plaques |
(213) |
| Liposomal-iodine |
CT |
Identifying tumor vascular structure |
(214) |
| Tantalum oxide |
CT |
Producing
greater imaging capability than iodine |
(215) |
| AuNP |
CT |
Incorporating RBC to image blood
flow |
(216) |
| AuNP |
CT |
Labeling
tumor cells to image tumor growth |
(217) |
| AuNP |
CT |
Imaging brain malignant gliomas
and enhancing radiotherapy |
(218) |
| AuNP |
CT |
AuNP with CT contrast capability |
(219) |
| Liposomal iodine |
CT |
Imaging tumor |
(220) |
| AuNP |
CT |
Tracking mesenchymal
stem cells |
(221) |
